Toshiba America Medical Systems (TAMS) has launched its new Celesteion Positron emission tomography (PET) /computed tomography (CT) high-performance system, for radiation and oncology imaging needs that include tumour detection, treatment evaluation and CT simulation.
The new system features 90cm CT and 88cm PET bore, more accurate CT and PET imaging, as well as provides fast imaging for reduced exam times.
The new Celesteion system, which is yet to receive 510(k) clearance, offers 70cm true CT and PET field-of-view and 85cm CT extended field-of-view.
In order to provide safer CT imaging, Celesteion comes standard with AIDR 3D, the company’s most advanced CT dose reduction technology.
The company said that the new PET/ CT system is also compliant with MITA’s XR-29 Smart Dose Standard.
Toshiba CT business unit senior director Satrajit Misra said: "Accuracy and efficiency are crucial under healthcare reform, and Celesteion is capable of producing high-quality images, while improving workflow for providers."
The company has unveiled the Celesteion PET/CT system for the first time at the Society of Nuclear Medicine and Molecular Imaging meeting, running from 7 to 11 June in St Louis, US.
Headquartered in Tustin, TAMS markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the US.
Image: Toshiba’s Celesteion CT system comes with the industry’s largest bore and widest field-of-view for better PET/CT imaging. Photo: courtesy of Toshiba Corporation.